Literature DB >> 18301286

New developments in optical coherence tomography for glaucoma.

Robert Chang1, Donald L Budenz.   

Abstract

PURPOSE OF REVIEW: Structural imaging is becoming a powerful adjunct for the diagnosis and progression of glaucoma. There are several competing technologies in this arena. Optical coherence tomography continues to evolve at a fast pace, so it can be challenging to keep up with the latest information. This review covers the recent papers relevant to optical coherence tomography for glaucoma. RECENT
FINDINGS: Retinal nerve fiber layer imaging by optical coherence tomography is reliable. Age, ethnicity, axial length and optic disc size can affect the machine's normative range. Scan quality can be affected by movement, media opacities, myopia and severity of disease. The sensitivity and specificity are variable across multiple studies. Despite this, the technology is beginning to help us understand the structure-function relationship in glaucoma.
SUMMARY: The next generation optical coherence tomography is around the corner. By understanding the current strengths and limitations of this advancing technology, one can better assess its use in clinical practice.

Entities:  

Mesh:

Year:  2008        PMID: 18301286     DOI: 10.1097/ICU.0b013e3282f36cdf

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  12 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Virtual histology of the human heart using optical coherence tomography.

Authors:  Christina M Ambrosi; Nader Moazami; Andrew M Rollins; Igor R Efimov
Journal:  J Biomed Opt       Date:  2009 Sep-Oct       Impact factor: 3.170

3.  Improving glaucoma detection using spatially correspondent clusters of damage and by combining standard automated perimetry and optical coherence tomography.

Authors:  Ali S Raza; Xian Zhang; Carlos G V De Moraes; Charles A Reisman; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

4.  Reproducibility of peripapillary retinal nerve fiber layer thickness with spectral domain cirrus high-definition optical coherence tomography in normal eyes.

Authors:  Samin Hong; Chan Yun Kim; Won Seok Lee; Gong Je Seong
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

5.  Evaluation of a Method for Estimating Retinal Ganglion Cell Counts Using Visual Fields and Optical Coherence Tomography.

Authors:  Ali S Raza; Donald C Hood
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

6.  [Health-economic aspects of glaucoma screening].

Authors:  C Hirneiss; A Niedermaier; M Kernt; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2010-02       Impact factor: 1.059

7.  Role of imaging in glaucoma diagnosis and follow-up.

Authors:  Gianmarco Vizzeri; Sara M Kjaergaard; Harsha L Rao; Linda M Zangwill
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

8.  Integration and fusion of standard automated perimetry and optical coherence tomography data for improved automated glaucoma diagnostics.

Authors:  Dimitrios Bizios; Anders Heijl; Boel Bengtsson
Journal:  BMC Ophthalmol       Date:  2011-08-04       Impact factor: 2.209

9.  Primary Open Angle Glaucoma and Post-LASIK Keratectasia.

Authors:  Mohammad-Reza Razeghinejad; Kouros Nouri-Mahdavi; Shamira Perera
Journal:  J Ophthalmic Vis Res       Date:  2010-07

10.  Cross-sectional study: Does combining optical coherence tomography measurements using the 'Random Forest' decision tree classifier improve the prediction of the presence of perimetric deterioration in glaucoma suspects?

Authors:  Koichiro Sugimoto; Hiroshi Murata; Hiroyo Hirasawa; Makoto Aihara; Chihiro Mayama; Ryo Asaoka
Journal:  BMJ Open       Date:  2013-10-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.